Semaglutide vs Bariatric Surgery Guide (2026)
Complete Guide & Evidence (2026)
Semaglutide vs bariatric surgery for obesity. Weight loss comparison (15-17% vs 25-35%), cost analysis over 5 years, durability, and complication rates.
Key Weight Loss Numbers
Mean total body weight loss in STEP trials at 68 weeks on 2.4 mg/week semaglutide.
Mean TBWL in SURMOUNT-1 at 72 weeks on 15 mg/week tirzepatide.
Average total body weight loss from Roux-en-Y gastric bypass at 1–2 years post-surgery.
Decision Framework
Choose GLP-1 Medication If…
BMI 27–40 with weight-related conditions. High surgical risk or surgical anxiety. Want reversible, medication-based approach. Willing to continue medication long-term. Have insurance coverage for GLP-
Consider Surgery If…
BMI >40 or >35 with severe comorbidities. Need durable results without daily medication. T2D remission is a primary goal. GLP-1s haven't provided adequate response. Insurance covers surgery but not me
Guide FAQs
Semaglutide vs bariatric surgery for obesity. Weight loss comparison (15-17% vs 25-35%), cost analysis over 5 years, durability, and complication rates.
Yes. Shotlee supports tracking Semaglutide Vs Surgery doses, side effects, and health metrics. It is free to use.
References
- [1]Clinical TrialWilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002.
- [2]Clinical TrialLincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT). N Engl J Med. 2023;389(24):2221-2232.
- [3]Clinical TrialGarvey WT et al. Two-year effects of semaglutide in adults with overweight or obesity (STEP 5). Nat Med. 2022;28:2083-2091.
Track Your Semaglutide Vs Surgery Protocol in Shotlee
Free dose logging, side effect tracking, and health metric monitoring for your complete protocol.
🚀 Use Shotlee for Free